A case of haploidentical stem cell transplantation for chronic active EB virus infection and literature review
-
摘要: 目的:探讨单倍体相合造血干细胞移植治疗慢性活动性EB病毒感染(CAEBV)的可行性。方法:采用马利兰+氟达拉滨+环磷酰胺+抗人T淋巴细胞球蛋白移植预处理方案,对1例8岁CAEBV患儿行HLA3/6母供女单倍体相合造血干细胞移植。结果:移植后第13天粒细胞植入,第16天血小板植入,第25天DNA指纹鉴定结果提示供者型完全植入。移植后第42天患者出现皮肤Ⅰ度移植物抗宿主病,治疗后皮疹完全消退。移植后CAEBV临床症状及体征消失,随访至移植后1年,多次复查EBV-DNA持续阴性。结论:单倍体相合造血干细胞移植可作为治疗CAEBV的有效手段。
-
关键词:
- 慢性活动性EB病毒感染 /
- 单倍体相合造血干细胞移植
Abstract: Objective: To explore the feasibility of haploidentical stem cell transplantation (haplo-HSCT) for chronic active EB virus (CAEBV) infection.Method: An 8-year-old girl with CAEBV infection underwent haplo-HSCT from her mother with a preparative regimen consisted of busulphan,fludarabine,cyclophosphamide and anti-human T-lymphocyte globulin.Result: The neutrophils and platelets engrafted on the 13th days 16th days,respectively.DNA fingerprint showed full donor-chimeric on the 25th days.Grade Ⅰ acute skin graft-versus-host disease occurred on the 42nd days and was controlled after cured.The clinical symptoms and signs of CAEBV disappeared with undetectable EBV-DNA copies after haplo-HSCT.Conclusion: The haplo-HSCT is an effective regimen for treating CAEBV infection. -
-
[1] OKANO M,KAWA K,KIMURA H,et al.Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection[J].Am J Hemotol,2005,80:64-69.
[2] COHEN J I,JAFFE E S,DALE J K,et,al.Characterization and treatment of chronic active Epstein-Barr virus infection:a 28-year experience in the United States[J].Blood,2011,117:5835-5849.
[3] ISHIMURA M,OHGA S,NOMURA A,et al.Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation[J].Am J Hematol,2005,80:207-212.
[4] HORWITZ E M,MAZIARZ R T,KEBRIAEI P.MSCs in hematopoietic cell transplantation[J].Biol Blood Marrow Transplant,2011,17(1 Suppl):S21-S29.
[5] DANDER E,LUCCHINI G,VINCI P,et al.Mesenchymal stromal cells for the treatment of graft-versus-host disease:understanding the in vivo biological effect through patient immune monitoring[J].Leukemia,2012,26:1681-1684.
[6] KEBRIAEI P,ISOLA L,BAHCECI E,et al.Adult human mesenchymal stem cells added to corticosteriod therapy for the treatment of acute graft-versus-host-disease[J].Biol Blood Marrow Transplant,2009,15:804-811.
-
计量
- 文章访问数: 53
- PDF下载数: 197
- 施引文献: 0